International Flavors & Fragrances Health & Biosciences — Selling and administrative expenses increased by 3.4% to $92.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.6%, from $81.00M to $92.00M. Over 3 years (FY 2022 to FY 2025), Health & Biosciences — Selling and administrative expenses shows an upward trend with a 7.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Rising expenses relative to revenue may indicate declining operational leverage or increased investment in sales infrastructure.
Operating costs related to the sales, marketing, and general administration of the Health & Biosciences segment. This in...
Standard SG&A metric used across all industries to measure operating efficiency.
iff_segment_health_biosciences_selling_and_administrative_expenses| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $70.50M | $70.50M | $70.50M | $70.50M | $80.00M | $80.00M | $80.00M | $80.00M | $88.00M | $89.00M | $96.00M | $95.00M | $81.00M | $91.00M | $87.00M | $89.00M | $92.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +13.5% | +0.0% | +0.0% | +0.0% | +10.0% | +1.1% | +7.9% | -1.0% | -14.7% | +12.3% | -4.4% | +2.3% | +3.4% |
| YoY Change | — | — | — | — | +13.5% | +13.5% | +13.5% | +13.5% | +10.0% | +11.3% | +20.0% | +18.8% | -8.0% | +2.2% | -9.4% | -6.3% | +13.6% |